Ebola Bundibugyo Virus Disease (BVD)
On May 17, 2026 the World Health Organization (WHO) declared a of international concern due to an outbreak of Ebola Bundibugyo Virus Disease (BVD) in the Democratic Republic of Congo (DRC) and Uganda. In response, the U.S. Department of State raised the to a Level 4: Do Not Travel. (The DRC and South Sudan have had Level 4 ratings for many years due to other risks.)
Disease Information: Ebola BVD is a type of virus that can cause illness in people. It is spread by contact with the blood or bodily fluids of an infected individual or someone who has died from the disease. It is also spread by contact with contaminated objects as well as some animals that are also infected. Symptoms include fever, headache, diarrhea, vomiting, stomach pains, and unexplained bleeding or bruising. The are currently no vaccines or specific treatments approved for the prevention or treatment of BVD. (Source: )
Outbound Travelers: Undergraduate travel to countries with a Level 4 advisory, including the DRC, South Sudan and Uganda, is prohibited. Given the threat to public and personal health, graduate and professional students, faculty and staff are strongly advised to postpone non-essential travel to the DRC, South Sudan and Uganda until further notice.
Inbound Travelers:
Inbound Travelers: The CDC has updated its guidance for to help reduce the risk of Ebola spreading in the U.S.